Document Format Files
| Seq | Description | Document | Type | Size |
|---|---|---|---|---|
| 1 | REGISTRATION STATEMENT | ea120601-s1_lanternpharma.htm | S-1 | 1927842 |
| 2 | CERTIFICATE OF CONVERSION (TEXAS) | ea120601fs1ex3-1i_lantern.htm | EX-3.1(I) | 18677 |
| 3 | CERTIFICATE OF CONVERSION (DELAWARE) | ea120601fs1ex3-1ii_lantern.htm | EX-3.1(II) | 9488 |
| 4 | CERTIFICATE OF INCORPORATION | ea120601fs1ex3-1iii_lantern.htm | EX-3.1(III) | 153161 |
| 5 | BYLAWS | ea120601fs1ex3-1iv_lantern.htm | EX-3.1(IV) | 156096 |
| 6 | FORM OF WARRANT (2014) | ea120601fs1ex4-1i_lantern.htm | EX-4.1(I) | 46338 |
| 7 | FORM OF WARRANT (2017) | ea120601fs1ex4-1ii_lantern.htm | EX-4.1(II) | 44741 |
| 8 | FORM OF WARRANT (2019) | ea120601fs1ex4-1iii_lantern.htm | EX-4.1(III) | 79929 |
| 9 | AMENDED AND RESTATED 2018 EQUITY INCENTIVE PLAN | ea120601fs1ex10-1_lantern.htm | EX-10.1 | 120634 |
| 10 | EMPLOYMENT AGREEMENT DATED JULY 23, 2018 WITH PANNA SHARMA | ea120601fs1ex10-2_lantern.htm | EX-10.2 | 118321 |
| 11 | FORM OF INDEMNIFICATION AGREEMENT | ea120601fs1ex10-3_lantern.htm | EX-10.3 | 95189 |
| 12 | AMENDED AND RESTATED INVESTORS' RIGHTS AGREEMENT | ea120601fs1ex10-4_lantern.htm | EX-10.4 | 222492 |
| 13 | AMENDED AND RESTATED RIGHT OF FIRST REFUSAL AND CO-SALE AGREEMENT | ea120601fs1ex10-5_lantern.htm | EX-10.5 | 174111 |
| 14 | AMENDED AND RESTATED VOTING AGREEMENT | ea120601fs1ex10-6_lantern.htm | EX-10.6 | 178455 |
| 15 | TECHNOLOGY LICENSE AGREEMENT DATED JANUARY 15,2015, WITH AF CHEMICALS LLC | ea120601fs1ex10-7_lantern.htm | EX-10.7 | 138166 |
| 16 | DRUG LICENSE AND DEVELOPMENT AGREEMENT DATED AS OF MAY 23, 2015 WITH ONCOLOGY VE | ea120601fs1ex10-8_lantern.htm | EX-10.8 | 563268 |
| 17 | ADDENDUM TO DRUG LICENSE AND DEVELOPMENT AGREEMENT WITH ONCOLOGY VENTURE A/S DAT | ea120601fs1ex10-9_lantern.htm | EX-10.9 | 196189 |
| 18 | AMENDMENT NO. 2 TO DRUG LICENSE AND DEVELOPMENT AGREEMENT WITH ONCOLOGY VENTURE | ea120601fs1ex10-10_lantern.htm | EX-10.10 | 16627 |
| 19 | ASSIGNMENT AGREEMENTDATED AS OF JANUARY 5, 2018 WITH BIONUMERIK PHARMACEUTICALS, | ea120601fs1ex10-11_lantern.htm | EX-10.11 | 477116 |
| 20 | ADDENDUM TO TECHNOLOGYLICENSE AGREEMENT DATED FEBRUARY 8, 2016, WITH AF CHEMICAL | ea120601fs1ex10-12_lantern.htm | EX-10.12 | 72248 |
| 21 | CODE OF BUSINESS CONDUCT AND ETHICS | ea120601fs1ex14-1_lantern.htm | EX-14.1 | 31134 |
| 22 | LIST OF SUBSIDIARY | ea120601fs1ex21-1_lantern.htm | EX-21.1 | 2178 |
| 23 | CONSENT OF EISNERAMPER LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM | ea120601fs1ex23-1_lantern.htm | EX-23.1 | 2908 |
| 24 | GRAPHIC | ex3-1i_002.jpg | GRAPHIC | 11345 |
| 25 | GRAPHIC | ex3-1i_003.jpg | GRAPHIC | 39808 |
| 26 | GRAPHIC | ex3-1ii_001.jpg | GRAPHIC | 11026 |
| 27 | GRAPHIC | ex3-1ii_002.jpg | GRAPHIC | 5001 |
| 28 | GRAPHIC | ex3-1iii_001.jpg | GRAPHIC | 11047 |
| 29 | GRAPHIC | ex3-1iii_002.jpg | GRAPHIC | 5001 |
| 30 | GRAPHIC | image_001.jpg | GRAPHIC | 3918 |
| 31 | GRAPHIC | image_002.jpg | GRAPHIC | 100866 |
| 32 | GRAPHIC | image_003.jpg | GRAPHIC | 154481 |
| 33 | GRAPHIC | image_004.jpg | GRAPHIC | 83771 |
| 34 | GRAPHIC | image_005.jpg | GRAPHIC | 46908 |
| 35 | GRAPHIC | image_005a.jpg | GRAPHIC | 45950 |
| 36 | GRAPHIC | image_006.jpg | GRAPHIC | 81650 |
| 37 | GRAPHIC | image_007.jpg | GRAPHIC | 40213 |
| 38 | GRAPHIC | image_008.jpg | GRAPHIC | 47737 |
| 39 | GRAPHIC | image_009.jpg | GRAPHIC | 93373 |
| 40 | GRAPHIC | image_010.jpg | GRAPHIC | 34596 |
| 41 | GRAPHIC | image_011.jpg | GRAPHIC | 24535 |
| 42 | GRAPHIC | image_012.jpg | GRAPHIC | 146936 |
| 43 | GRAPHIC | image_013.jpg | GRAPHIC | 3089 |
| 44 | GRAPHIC | image_014.jpg | GRAPHIC | 32202 |
| 45 | GRAPHIC | image_015.jpg | GRAPHIC | 41464 |
| 46 | GRAPHIC | image_016.jpg | GRAPHIC | 44903 |
| 47 | GRAPHIC | image_016a.jpg | GRAPHIC | 4326 |
| 48 | GRAPHIC | image_017.jpg | GRAPHIC | 30632 |
| 49 | GRAPHIC | image_018.jpg | GRAPHIC | 20859 |
| 50 | GRAPHIC | image_019.jpg | GRAPHIC | 22197 |
| 51 | GRAPHIC | image_020.jpg | GRAPHIC | 26035 |
| 52 | GRAPHIC | image_021.jpg | GRAPHIC | 21253 |
| 53 | GRAPHIC | image_022.jpg | GRAPHIC | 19049 |
| 54 | GRAPHIC | image_023.jpg | GRAPHIC | 26470 |
| 55 | GRAPHIC | image_024.jpg | GRAPHIC | 27487 |
| 56 | GRAPHIC | image_025.jpg | GRAPHIC | 5068 |
| 57 | GRAPHIC | image_026.jpg | GRAPHIC | 3419 |
| Complete submission text file | 0001213900-20-009332.txt | 6664250 |
IRS No.: 463973463 | State of Incorp.: TX | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-237714 | Film No.: 20796183
SIC: 2834 Pharmaceutical Preparations
